The content is available as a PDF (277.9 KB).
References
- 1.Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan A V. Hyper inflammatory syndrome in children associated with COVID-19: Need for awareness [published online ahead of print, 2020 Jul 15]. Indian Pediatr. 2020; S097475591600208. [DOI] [PMC free article] [PubMed]
- 2.Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyper Inflam-mation in COVID-19. Version 1 [published online ahead of print, 2020 Jul 23]. Arthritis Rheumatol. 2020;10.1002/art.41454.
- 3.Li H, Chen K, Liu M, Xu H, Xu Q. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. J Infect. 2020;81:115–20. doi: 10.1016/j.jinf.2020.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shulman ST. Pediatric coronavirus disease-2019-associated multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9:285–6. doi: 10.1093/jpids/piaa062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cortegiani A, Ippolito M, Greco M, et al. Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Pulmonol. 2020;S2531-0437:30153–7. doi: 10.1016/j.pulmoe.2020.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]